You have 9 free searches left this month | for more free features.

Type 3

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gaucher Disease, Type 3 Trial (Gene therapy, Enzyme Replacement Agent)

Not yet recruiting
  • Gaucher Disease, Type 3
  • Gene therapy
  • Enzyme Replacement Agent
  • (no location specified)
Apr 14, 2023

MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER

Not yet recruiting
  • Gaucher Disease, Type 3
  • No intervention
  • Minneapolis, Minnesota
    University of Minnesota
Oct 16, 2022

Poliomyelitis Trial in Panama City (Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral

Not yet recruiting
  • Poliomyelitis
  • Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
  • Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
  • Panama City, Panama
  • +3 more
Dec 14, 2022

Group 3 Pulmonary Hypertension Trial (recombinant human brain natriuretic peptide, Placebo)

Not yet recruiting
  • Group 3 Pulmonary Hypertension
  • recombinant human brain natriuretic peptide
  • Placebo
  • (no location specified)
Jan 30, 2023

Spinal Muscular Atrophy Trial (NMD670, Placebo)

Not yet recruiting
  • Spinal Muscular Atrophy
  • (no location specified)
Mar 29, 2023

Hamstring Injury, Muscle Rupture, Hamstring Sprain Trial (NMES+, Rehab)

Not yet recruiting
  • Hamstring Injury
  • +2 more
  • NMES+
  • Rehab
  • (no location specified)
Mar 29, 2023

Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

Not yet recruiting
  • Poliomyelitis
  • Novel oral poliomyelitis vaccine type 1 (nOPV1)
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research
Nov 14, 2023

Poliomyelitis Trial in United States (Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin

Active, not recruiting
  • Poliomyelitis
  • Novel Oral Polio Vaccine Type 1 (nOPV1)
  • +3 more
  • Baltimore, Maryland
  • +3 more
Aug 24, 2022

Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease Trial in Nijmegen (VO659)

Recruiting
  • Spinocerebellar Ataxia Type 1
  • +2 more
  • Nijmegen, Netherlands
    Radbout University Medical Centre
Apr 7, 2023

Spinocerebellar Ataxia Type 3 Trial in Fuzhou (Active repetitive transcranial magnetic stimulation, Sham repetitive transcranial

Completed
  • Spinocerebellar Ataxia Type 3
  • Active repetitive transcranial magnetic stimulation
  • Sham repetitive transcranial magnetic stimulation
  • Fuzhou, Fujian, China
    Department of Neurology ,First Affiliated Hospital Fujian Medica
Aug 14, 2022

Characterization and Type 3c Diabetes Mellitus Secondary to

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Data Management and Monitoring
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 25, 2022

Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III Trial (Bone marrow-derived mesenchymal stromal cells (MSCs))

Not yet recruiting
  • Osteogenesis Imperfecta
  • Osteogenesis Imperfecta Type III
  • Bone marrow-derived mesenchymal stromal cells (MSCs)
  • (no location specified)
Nov 28, 2022

Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Worldwide (venglustat (GZ402671), imiglucerase)

Active, not recruiting
  • Gaucher Disease Type 1
  • Gaucher Disease Type 3
  • New Haven, Connecticut
  • +6 more
Aug 9, 2022

Nicotine Use Disorder Trial (E-liquid coolant (no WS-3) (1), E-liquid coolant (Low WS-3) (1), E-liquid coolant (High WS-3) (1))

Not yet recruiting
  • Nicotine Use Disorder
  • E-liquid coolant (no WS-3) (1)
  • +8 more
  • (no location specified)
Jul 7, 2023

Diabetes, Type 2, Diabetes, Type 1, Gastroparesis With Diabetes Trial in Cleveland (FreeStyle Libre 3 continuous glucose

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • FreeStyle Libre 3 continuous glucose monitoring sensor
  • Cleveland, Ohio
    Cleveland Clinic Foundation
Sep 6, 2023

Von Willebrand Disease Trial (Alphanate SD/HT)

Active, not recruiting
  • Von Willebrand Disease
  • Alphanate SD/HT
  • (no location specified)
May 5, 2022

E-Cig Use Trial (E-liquid coolant (WS-3, 0.1%), E-liquid coolant (WS-3, 0.25%), E-liquid coolant (WS-3, 0.5%))

Not yet recruiting
  • E-Cig Use
  • E-liquid coolant (WS-3, 0.1%)
  • +9 more
  • (no location specified)
Jun 28, 2023

Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3 Trial in New York (High-Intensity

Recruiting
  • Spinocerebellar Ataxia Type 1
  • +4 more
  • High-Intensity Aerobic Exercise Prior to Balance Training
  • Low-Intensity Exercise Prior to Balance Training
  • New York, New York
    Teachers College, Columbia University
Apr 21, 2023

Type 2 Diabetes, Lipid Metabolism Disorder, Fatty Acid Metabolism Disorder Trial in Lianshui (omega-3 polyunsaturated fatty

Completed
  • Type 2 Diabetes Mellitus
  • +2 more
  • omega-3 polyunsaturated fatty acids
  • corn oil
  • Lianshui, Jiangsu, China
    Lian Shui People's Hospital
Oct 2, 2023

Pancretic Cancer, Diabete Mellitus Trial (Metformin or insulin treatment)

Not yet recruiting
  • Pancretic Cancer
  • Diabete Mellitus
  • Metformin or insulin treatment
  • (no location specified)
Mar 23, 2022

Sensory Profiles, Nociplastic Pain, Low Back Pain Trial

Recruiting
  • Sensory Profiles, Nociplastic Pain, Low Back Pain
    • Zwolle, Overijssel, Netherlands
      Fysiomobilae
    Oct 12, 2022

    Diabetes, Type 1 Trial in Cairo (oral omega-3 fatty acids supplementation, Placebo)

    Completed
    • Diabetes Mellitus, Type 1
    • oral omega-3 fatty acids supplementation
    • Placebo
    • Cairo, Egypt
      Nancy Elbarbary
    Aug 4, 2023

    Gaucher's Disease Type III Trial in Fairfax, Beijing, Guangzhou (Venglustat, imiglucerase)

    Recruiting
    • Gaucher's Disease Type III
    • New Haven, Connecticut
    • +13 more
    Jan 13, 2023

    Transcranial Alternating Current Stimulation(tACS)on Cerebellar

    Recruiting
    • Spinocerebellar Ataxia Type 3
    • Multiple System Atrophy-cerebellar Type
    • Transcranial Alternating Current Stimulation
    • Fuzhou, Fujian, China
      Department of Neurology, The First Affiliated Hospital Fujian Me
    Oct 6, 2022

    Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

    Not yet recruiting
    • Diabetes Mellitus Type 2 With Proteinuria
    • +12 more
    • Empagliflozin 10 MG
    • +6 more
    • (no location specified)
    Oct 17, 2023